EUVIMEDEUVIMED entdecken
Kohortenstudie

L26/P-722 Higher pre-treatment serum phosphate is associated with improved live birth rates in fresh ICSI cycles: A retrospective cohort study

Z. Wang, Q. Shi, X. Shen, Y. Jiang, J. Mei, N. Kong, G. Yan, H. Sun

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1049 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von Z. Wang und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Is pre-treatment serum phosphate associated with live birth rates (LBR) after the first IVF/ICSI cycle with fresh embryo transfer? Summary answer Higher fasting serum phosphate was linearly associated with higher live birth rates, particularly in ICSI cycles, despite showing no correlation with oocyte or embryo count. What is known already Oocyte developmental competence is central to ART success and may be influenced by the metabolic milieu during folliculogenesis. Inorganic phosphate is integral to cellular energetics (ATP production) and phosphorylation signaling. While hypo- or hyperphosphatemia are known pathological states, the relevance of physiological variations in circulating phosphate to ovarian stimulation outcomes and clinical pregnancy in infertile women remains largely unexplored. Study design, size, duration Retrospective cohort study including 2,226 women undergoing their first oocyte retrieval with fresh embryo transfer at a large tertiary fertility center between January 2022 and June 2024. Participants/materials, setting, methods Fasting serum phosphate (mmol/L) measured within 180 days pre-retrieval was analyzed by quartiles and per 1-SD increase. The primary outcome was live birth (≥28 weeks). Logistic regression estimated adjusted odds ratios (aORs). Negative binomial models evaluated MII oocyte and usable embryo counts. Restricted cubic splines characterized dose–response relationships. Interaction analyses assessed effect modification by fertilization method (IVF vs. ICSI) and BMI. Main results and the role of chance Live birth rates increased from 56% in the lowest phosphate quartile (Q1) to 66% in the highest (Q4) (P for trend=0.003). In fully adjusted models, women in Q4 had significantly higher odds of live birth compared with Q1 (aOR 1.40, 95% CI: 1.09–1.80; P = 0.008). Modeled continuously, each 1-SD increase in serum phosphate was associated with 15% higher odds of live birth (aOR 1.15, 95% CI: 1.06–1.26; P = 0.002). The dose–response relationship was linear (P for non-linearity=0.31). Crucially, serum phosphate was not associated with MII oocyte counts (adjusted IRR 0.99) or usable embryo counts (adjusted IRR 0.99), suggesting a qualitative rather than quantitative effect. A significant interaction was observed by fertilization method (P for interaction=0.001): the beneficial association was robust in ICSI cycles (aOR per 1-SD: 1.65, 95% CI: 1.30–2.10) but not statistically significant in conventional IVF cycles (aOR 1.08, 95% CI: 0.98–1.19). No interaction was found for BMI. Limitations, reasons for caution Limitations include the observational single-center design and potential selection bias from restricting the cohort to fresh embryo transfers. A single phosphate measurement may reflect transient rather than long-term metabolic status. Residual confounding from unmeasured dietary factors or parathyroid hormone levels cannot be excluded. Wider implications of the findings Pre-treatment serum phosphate represents a routine marker positively associated with live birth, independent of oocyte yield. The specific benefit in ICSI cycles suggests phosphate may play a critical role in oocyte energetic resilience or fertilization competence under mechanical stress. These findings warrant validation and mechanistic investigation. Trial registration number No

Zitieren

APA

Wang, Z., Shi, Q., Shen, X., Jiang, Y., Mei, J., Kong, N., Yan, G., & Sun, H. (2026). L26/P-722 Higher pre-treatment serum phosphate is associated with improved live birth rates in fresh ICSI cycles: A retrospective cohort study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1049

Vancouver

Wang Z, Shi Q, Shen X, Jiang Y, Mei J, Kong N, et al. L26/P-722 Higher pre-treatment serum phosphate is associated with improved live birth rates in fresh ICSI cycles: A retrospective cohort study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1049

BibTeX
@article{Wang2026,
  author = {Wang, Z. and Shi, Q. and Shen, X. and Jiang, Y. and Mei, J. and Kong, N. and Yan, G. and Sun, H.},
  title = {L26/P-722 Higher pre-treatment serum phosphate is associated with improved live birth rates in fresh ICSI cycles: A retrospective cohort study},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1049}
}
Kostenlos starten →